Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Array Biopharma, Inc -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (107)	6/12/2011 4:29:20 PM
From: mcbio	Read Replies (1) \| Respond to of 321

Conway had a recent insider buy (hadn't been any of those in awhile). Any current thoughts on ARRY? I'm planning to double my position on Monday.

To: scaram(o)uche who wrote (107)	6/15/2011 1:46:40 PM
From: scaram(o)uche	1 Recommendation Read Replies (1) \| Respond to of 321

>> Sick of you, Conway! You haven't fed the pipe as many expected, and you let pricks Caruthers and Moore go on with their share dribble. << So the company restructures, cutting back on bench grunts??... the guys/gals who fill a pipe! For each "Caruthers", you could retain about four bench grunts. For each "Moore"? Ditto. As biotech investors, we watch this model all the time.... three high-paid guys at the top -- CEO, CFO and General Ahole -- take biotech after biotech down the drain, ultimately requiring a large percentage of operating expenses just to support their salaries. For this!!...... finance.yahoo.com